Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: A molecular and clinicopathologic study of 82 cases

Clinical Cancer Research

Volumn 7, Issue 12, 2001, Pages 3977-3987

  Antonescu, Cristina R ^a   Tschernyavsky, Sylvia J ^a   Decuseara, Ramona ^a   Woodruff, James M ^a   Ladanyi, Marc ^a   Leung, Denis H ^a   Brennan, Murray F ^a   Bridge, Julia A ^b   Neff, James R ^b   Goldblum, John R ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; FEMALE; FUSION GENE; GENE LOCATION; GENE OVEREXPRESSION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MYXOSARCOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; TISSUE NECROSIS;

ADULT; AGED; CCAAT-ENHANCER-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 16; DNA PRIMERS; EXONS; FEMALE; GENES, P53; HUMANS; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEIN FUS; SURVIVAL RATE; TIME FACTORS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 0035675835     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases
2. Monoclonality of multifocal myxoid liposarcoma: Confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements
3. Rearrangements of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)
4. Fusion of CHOP to a novel RNA-binding protein in a human myxoid liposarcoma
5. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in myxoid liposarcoma
6. Fusion of the EWS and CHOP genes in myxoid liposarcoma
7. Additional evidence of a variant translocation t(12;22) with EWS-CHOP fusion in myxoid liposarcoma: Clinicopathologic features
8. The role of C/EBP genes in adipocyte differentiation
9. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription
10. Fusion genes in solid tumors
11. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the (12;16) translocation
12. Prognostic impact of P53 status in Ewing sarcoma
13. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications
14. Myxoid liposarcoma. A proposal for a two tier grading system
15. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma
16. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone
17. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma. Absence in predominantly myxoid well-differentiated liposarcomas
18. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma
19. Prognostic implications of P53 nuclear overexpression and high proliferation index of Ki-67 in adult soft tissue sarcomas
20. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of translin and topoisomerase II in the process of translocation
21. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma
22. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues
23. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis
24. Analysis of FUS-CHOP fusion transcript in different types of soft tissue liposarcoma and their diagnostic implications
25. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
26. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma
27. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma
28. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma. A multi-institutional study of 243 patients
29. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing’s sarcoma
30. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21)
31. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS
32. Liposarcoma: A population based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content
33. Multifocal extremity sarcoma: An uncommon and controversial entity
34. Will we ever reliably predict prognosis in a patient with myxoid round cell liposarcoma?
35. Liposarcomas and atypical lipomatous tumors: A study of 66 cases followed for a minimum of 10 years
36. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases
37. No rearrangements of the CHOP gene in malignant fibrous histiocytoma
38. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas
39. Correlation between clinicopathological features and karyotype in lipomatous tumours. A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group
40. Dedifferentiated myxoid liposarcoma: A clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma
41. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumours
42. Lipoblastoma and liposarcoma in children: An analysis of 9 cases with review of the literature
43. Myxoid liposarcoma in a 2-year old girl
44. Limited role of TP53 and TP53-related genes in myxoid liposarcoma
45. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma
46. Immunohistochemical analysis in myxoid/round cell liposarcoma of the extremities